Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...

Traditionally, blood sugar regulation has been attributed to the hormones insulin and glucagon, both produced by the pancreas. Insulin lowers blood glucose by promoting its uptake into cells ...

Glucagon is a hormone produced by α cells in the pancreas. It works alongside insulin to regulate blood sugar levels, raising them when they drop too low. However, in people with type 2 diabetes ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.

The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 million in the fourth quarter.

ADA guidelines state that “glucagon should be prescribed for all individuals taking insulin or at high risk for hypoglycemia” and that ready-to-use preparations are preferred. Despite that ...

Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to list on the Nasdaq under the symbol “BBNX.” ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...